ES2595434T3 - Composiciones oromucosales líquidas de estradiol - Google Patents

Composiciones oromucosales líquidas de estradiol Download PDF

Info

Publication number
ES2595434T3
ES2595434T3 ES13700206.9T ES13700206T ES2595434T3 ES 2595434 T3 ES2595434 T3 ES 2595434T3 ES 13700206 T ES13700206 T ES 13700206T ES 2595434 T3 ES2595434 T3 ES 2595434T3
Authority
ES
Spain
Prior art keywords
estradiol
solution
alcohol
dose
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13700206.9T
Other languages
English (en)
Spanish (es)
Inventor
Franciscus Wilhelmus Henricus Maria Merkus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INNOTESTO bvba
Original Assignee
INNOTESTO bvba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INNOTESTO bvba filed Critical INNOTESTO bvba
Application granted granted Critical
Publication of ES2595434T3 publication Critical patent/ES2595434T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES13700206.9T 2012-01-04 2013-01-04 Composiciones oromucosales líquidas de estradiol Active ES2595434T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1200062.6A GB201200062D0 (en) 2012-01-04 2012-01-04 Estradiol oromucosal liquid compositions
GB201200062 2012-01-04
PCT/EP2013/050110 WO2013102665A1 (fr) 2012-01-04 2013-01-04 Compositions d'œstradiol liquide oro-muqueux

Publications (1)

Publication Number Publication Date
ES2595434T3 true ES2595434T3 (es) 2016-12-30

Family

ID=45755705

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13700206.9T Active ES2595434T3 (es) 2012-01-04 2013-01-04 Composiciones oromucosales líquidas de estradiol

Country Status (10)

Country Link
US (2) US9402811B2 (fr)
EP (1) EP2800571B1 (fr)
CN (1) CN104105487A (fr)
AU (1) AU2013207215B2 (fr)
BR (1) BR112014016510A8 (fr)
CA (1) CA2861141A1 (fr)
DK (1) DK2800571T3 (fr)
ES (1) ES2595434T3 (fr)
GB (1) GB201200062D0 (fr)
WO (1) WO2013102665A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8801670A (nl) 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5073374A (en) 1988-11-30 1991-12-17 Schering Corporation Fast dissolving buccal tablet
JPH06321771A (ja) 1992-07-31 1994-11-22 Tanabe Seiyaku Co Ltd 経皮投与用基剤
US5766620A (en) * 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
US5955098A (en) 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
AU2190697A (en) * 1996-04-12 1997-11-07 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20070219171A1 (en) 2003-10-23 2007-09-20 Waterlead Limited Transdermal Pharmaceutical Spray Formulations Comprising a Vp/Va Copolymer and a Non-Aquous Vehicle
CA2546404A1 (fr) 2003-11-19 2005-06-02 Acrux Dds Pty Ltd. Methode et composition permettant de traiter ou de prevenir l'amylose
CN101426475A (zh) * 2006-04-21 2009-05-06 安塔雷斯制药Ipl股份公司 使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
EP1867321A3 (fr) 2006-06-07 2008-11-19 Familplan Consulting Ltd. Produit pharmaceutique adapté à l'administration transmucosale orale comportant un agent pharmaceutique
AR068408A1 (es) 2007-09-14 2009-11-18 Drugtech Corp Pulverizacion de hormonas transdermicas
CN101945646A (zh) 2008-02-13 2011-01-12 拜耳先灵医药股份有限公司 含雌二醇的药物递送系统
DE102009007771B4 (de) 2009-02-05 2012-02-16 Bayer Schering Pharma Aktiengesellschaft Bukkales Applikationssystem, 17α-Estradiol enthaltend

Also Published As

Publication number Publication date
CN104105487A (zh) 2014-10-15
AU2013207215B2 (en) 2017-10-26
AU2013207215A1 (en) 2014-07-24
DK2800571T3 (da) 2016-10-24
GB201200062D0 (en) 2012-02-15
US20140371191A1 (en) 2014-12-18
BR112014016510A8 (pt) 2017-07-04
EP2800571A1 (fr) 2014-11-12
EP2800571B1 (fr) 2016-09-21
US9402811B2 (en) 2016-08-02
WO2013102665A1 (fr) 2013-07-11
US20160256473A1 (en) 2016-09-08
BR112014016510A2 (pt) 2017-06-13
CA2861141A1 (fr) 2013-07-11

Similar Documents

Publication Publication Date Title
ES2595434T3 (es) Composiciones oromucosales líquidas de estradiol
ES2641613T3 (es) Gel transdérmico de Nestorone®/Estradiol
ES2299077T3 (es) Composición en forma de spray que contiene la asociación de calcitriol y de propionato de clobetasol, una fase alcoholica, al menos una silicona volátil y una fase oleosa no volátil.
ES2586122T3 (es) Formulaciones de testosterona
ES2539582T3 (es) Soluciones de testosterona para el tratamiento del déficit de testosterona
JP4825305B2 (ja) 経皮吸収製剤
EP2266573B1 (fr) Formulation de fulvestrant
ES2626134T3 (es) Composiciones de bepotastina
ES2298264T3 (es) Composicion topica que contiene al menos una vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
ES2628218T3 (es) Uso de una composición espumable esencialmente libre de ingredientes farmacéuticamente activos para el tratamiento de la piel humana
ES2368535T3 (es) Composición tópica de poliafrón con vitamina d y corticosteroide.
ES2330188T3 (es) Composicion farmaceutica en forma de gel o de solucion a base de dihidrotestoterona, su procedimiento de preparacion y sus utilizaciones.
ES2933479T3 (es) Estabilidad mejorada de formulaciones de progestágenos
US20110195114A1 (en) Transdermal delivery systems for active agents
RO121628B1 (ro) Compoziţie medicinală, topică, pulverizabilă,dozator care o conţine, procedeu de realizare a dozatorului şi utilizarea compoziţiei menţionate
EP3267978B1 (fr) Compositions topiques comprenant un corticostéroïde
ES2455521T3 (es) Tratamiento de síntomas asociados con la menopausia
CN112107544A (zh) 右美托咪定鼻喷剂、其制备方法及应用
Algin-Yapar et al. Transdermal spray in hormone delivery
ES2296209T5 (es) Composición en forma de un spray que comprende una combinación de propionato de clobetasol y calcitriol, una fase alcohólica y una fase oleosa.
TW200840595A (en) Oral contraceptive spray
PT1406591E (pt) Composição farmacêutica para administração por via nasal de estradiol e de norestisterona